Genetic variation inGlutamate Receptor, Ionotropic, NMDA-activated 2 A and 2B (GRIN2A and GRIN2B)subunits has been investigated regarding the risk of schizophrenia and response toclozapine10, 11, 12, 13, 14. The gene discussed is GRIN2B; the disease is schizophrenia.